Financials data is unavailable for this security.
View more
Year on year Brooks Laboratories Ltd grew revenues 25.76% from 632.05m to 794.86m while net income improved from a loss of 209.00m to a smaller loss of 195.92m.
Gross margin | 29.09% |
---|---|
Net profit margin | -21.46% |
Operating margin | 2.13% |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, Brooks Laboratories Ltd increased its cash reserves by 440.95%, or 1.02m. Cash Flow from Financing totalled 96.01m or 12.08% of revenues. In addition the company used 96.81m for operations while cash from investing totalled 1.82m.
Cash flow per share | -6.16 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -- |
---|---|
Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
Current ratio | -- |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼